Report Detail

Request for Sample of this report

Pharma & Healthcare Global EGFR-TKI Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4750656
    • |
  • 05 October, 2026
    • |
  • Global
    • |
  • 130 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global EGFR-TKI market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
EGFR-TKI (epidermal growth factor receptor tyrosine kinase inhibitors) are a class of targeted therapies designed to treat cancers driven by mutations in the EGFR gene, particularly non-small cell lung cancer (NSCLC).These drugs work by specifically inhibiting the tyrosine kinase activity of the EGFR.
This report is a detailed and comprehensive analysis for global EGFR-TKI market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global EGFR-TKI market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global EGFR-TKI market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global EGFR-TKI market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global EGFR-TKI market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for EGFR-TKI
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global EGFR-TKI market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Roche, Betta Pharma, Boehringer Ingelheim Pharmaceuticals, Pfizer, Chengdu Brilliant Pharmaceuticals, Hansoh Pharma, ArriVent Biopharma, Hanmi Pharmaceutical, Johnson & Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
EGFR-TKI market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Gefitinib
Erlotinib
Icotinib
Afatinib
Dacomitinib
Osimertinib
Aumolertinib
Furmonertinib
Lazertinib
Other
Market segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Major players covered
AstraZeneca
Roche
Betta Pharma
Boehringer Ingelheim Pharmaceuticals
Pfizer
Chengdu Brilliant Pharmaceuticals
Hansoh Pharma
ArriVent Biopharma
Hanmi Pharmaceutical
Johnson & Johnson
Yuhan Corporation
Shanghai Allist Pharmaceuticals
Wanbang Biopharmaceuticals
Beacon Pharma
Drug International
Teva
Mylan
Glenmark Pharmaceuticals
Cipla
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe EGFR-TKI product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of EGFR-TKI, with price, sales quantity, revenue, and global market share of EGFR-TKI from 2021 to 2026.
Chapter 3, the EGFR-TKI competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the EGFR-TKI breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and EGFR-TKI market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of EGFR-TKI.
Chapter 14 and 15, to describe EGFR-TKI sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global EGFR-TKI Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Gefitinib
    • 1.3.3 Erlotinib
    • 1.3.4 Icotinib
    • 1.3.5 Afatinib
    • 1.3.6 Dacomitinib
    • 1.3.7 Osimertinib
    • 1.3.8 Aumolertinib
    • 1.3.9 Furmonertinib
    • 1.3.10 Lazertinib
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global EGFR-TKI Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital and Clinic
    • 1.4.3 Retail Pharmacies
    • 1.4.4 Other
  • 1.5 Global EGFR-TKI Market Size & Forecast
    • 1.5.1 Global EGFR-TKI Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global EGFR-TKI Sales Quantity (2021-2032)
    • 1.5.3 Global EGFR-TKI Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 AstraZeneca
    • 2.1.1 AstraZeneca Details
    • 2.1.2 AstraZeneca Major Business
    • 2.1.3 AstraZeneca EGFR-TKI Product and Services
    • 2.1.4 AstraZeneca EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 AstraZeneca Recent Developments/Updates
  • 2.2 Roche
    • 2.2.1 Roche Details
    • 2.2.2 Roche Major Business
    • 2.2.3 Roche EGFR-TKI Product and Services
    • 2.2.4 Roche EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Roche Recent Developments/Updates
  • 2.3 Betta Pharma
    • 2.3.1 Betta Pharma Details
    • 2.3.2 Betta Pharma Major Business
    • 2.3.3 Betta Pharma EGFR-TKI Product and Services
    • 2.3.4 Betta Pharma EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Betta Pharma Recent Developments/Updates
  • 2.4 Boehringer Ingelheim Pharmaceuticals
    • 2.4.1 Boehringer Ingelheim Pharmaceuticals Details
    • 2.4.2 Boehringer Ingelheim Pharmaceuticals Major Business
    • 2.4.3 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Product and Services
    • 2.4.4 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
  • 2.5 Pfizer
    • 2.5.1 Pfizer Details
    • 2.5.2 Pfizer Major Business
    • 2.5.3 Pfizer EGFR-TKI Product and Services
    • 2.5.4 Pfizer EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Pfizer Recent Developments/Updates
  • 2.6 Chengdu Brilliant Pharmaceuticals
    • 2.6.1 Chengdu Brilliant Pharmaceuticals Details
    • 2.6.2 Chengdu Brilliant Pharmaceuticals Major Business
    • 2.6.3 Chengdu Brilliant Pharmaceuticals EGFR-TKI Product and Services
    • 2.6.4 Chengdu Brilliant Pharmaceuticals EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
  • 2.7 Hansoh Pharma
    • 2.7.1 Hansoh Pharma Details
    • 2.7.2 Hansoh Pharma Major Business
    • 2.7.3 Hansoh Pharma EGFR-TKI Product and Services
    • 2.7.4 Hansoh Pharma EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Hansoh Pharma Recent Developments/Updates
  • 2.8 ArriVent Biopharma
    • 2.8.1 ArriVent Biopharma Details
    • 2.8.2 ArriVent Biopharma Major Business
    • 2.8.3 ArriVent Biopharma EGFR-TKI Product and Services
    • 2.8.4 ArriVent Biopharma EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 ArriVent Biopharma Recent Developments/Updates
  • 2.9 Hanmi Pharmaceutical
    • 2.9.1 Hanmi Pharmaceutical Details
    • 2.9.2 Hanmi Pharmaceutical Major Business
    • 2.9.3 Hanmi Pharmaceutical EGFR-TKI Product and Services
    • 2.9.4 Hanmi Pharmaceutical EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Hanmi Pharmaceutical Recent Developments/Updates
  • 2.10 Johnson & Johnson
    • 2.10.1 Johnson & Johnson Details
    • 2.10.2 Johnson & Johnson Major Business
    • 2.10.3 Johnson & Johnson EGFR-TKI Product and Services
    • 2.10.4 Johnson & Johnson EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Johnson & Johnson Recent Developments/Updates
  • 2.11 Yuhan Corporation
    • 2.11.1 Yuhan Corporation Details
    • 2.11.2 Yuhan Corporation Major Business
    • 2.11.3 Yuhan Corporation EGFR-TKI Product and Services
    • 2.11.4 Yuhan Corporation EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Yuhan Corporation Recent Developments/Updates
  • 2.12 Shanghai Allist Pharmaceuticals
    • 2.12.1 Shanghai Allist Pharmaceuticals Details
    • 2.12.2 Shanghai Allist Pharmaceuticals Major Business
    • 2.12.3 Shanghai Allist Pharmaceuticals EGFR-TKI Product and Services
    • 2.12.4 Shanghai Allist Pharmaceuticals EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Shanghai Allist Pharmaceuticals Recent Developments/Updates
  • 2.13 Wanbang Biopharmaceuticals
    • 2.13.1 Wanbang Biopharmaceuticals Details
    • 2.13.2 Wanbang Biopharmaceuticals Major Business
    • 2.13.3 Wanbang Biopharmaceuticals EGFR-TKI Product and Services
    • 2.13.4 Wanbang Biopharmaceuticals EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Wanbang Biopharmaceuticals Recent Developments/Updates
  • 2.14 Beacon Pharma
    • 2.14.1 Beacon Pharma Details
    • 2.14.2 Beacon Pharma Major Business
    • 2.14.3 Beacon Pharma EGFR-TKI Product and Services
    • 2.14.4 Beacon Pharma EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Beacon Pharma Recent Developments/Updates
  • 2.15 Drug International
    • 2.15.1 Drug International Details
    • 2.15.2 Drug International Major Business
    • 2.15.3 Drug International EGFR-TKI Product and Services
    • 2.15.4 Drug International EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Drug International Recent Developments/Updates
  • 2.16 Teva
    • 2.16.1 Teva Details
    • 2.16.2 Teva Major Business
    • 2.16.3 Teva EGFR-TKI Product and Services
    • 2.16.4 Teva EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Teva Recent Developments/Updates
  • 2.17 Mylan
    • 2.17.1 Mylan Details
    • 2.17.2 Mylan Major Business
    • 2.17.3 Mylan EGFR-TKI Product and Services
    • 2.17.4 Mylan EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Mylan Recent Developments/Updates
  • 2.18 Glenmark Pharmaceuticals
    • 2.18.1 Glenmark Pharmaceuticals Details
    • 2.18.2 Glenmark Pharmaceuticals Major Business
    • 2.18.3 Glenmark Pharmaceuticals EGFR-TKI Product and Services
    • 2.18.4 Glenmark Pharmaceuticals EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Glenmark Pharmaceuticals Recent Developments/Updates
  • 2.19 Cipla
    • 2.19.1 Cipla Details
    • 2.19.2 Cipla Major Business
    • 2.19.3 Cipla EGFR-TKI Product and Services
    • 2.19.4 Cipla EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Cipla Recent Developments/Updates

3 Competitive Environment: EGFR-TKI by Manufacturer

  • 3.1 Global EGFR-TKI Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global EGFR-TKI Revenue by Manufacturer (2021-2026)
  • 3.3 Global EGFR-TKI Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of EGFR-TKI by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 EGFR-TKI Manufacturer Market Share in 2025
    • 3.4.3 Top 6 EGFR-TKI Manufacturer Market Share in 2025
  • 3.5 EGFR-TKI Market: Overall Company Footprint Analysis
    • 3.5.1 EGFR-TKI Market: Region Footprint
    • 3.5.2 EGFR-TKI Market: Company Product Type Footprint
    • 3.5.3 EGFR-TKI Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global EGFR-TKI Market Size by Region
    • 4.1.1 Global EGFR-TKI Sales Quantity by Region (2021-2032)
    • 4.1.2 Global EGFR-TKI Consumption Value by Region (2021-2032)
    • 4.1.3 Global EGFR-TKI Average Price by Region (2021-2032)
  • 4.2 North America EGFR-TKI Consumption Value (2021-2032)
  • 4.3 Europe EGFR-TKI Consumption Value (2021-2032)
  • 4.4 Asia-Pacific EGFR-TKI Consumption Value (2021-2032)
  • 4.5 South America EGFR-TKI Consumption Value (2021-2032)
  • 4.6 Middle East & Africa EGFR-TKI Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global EGFR-TKI Sales Quantity by Type (2021-2032)
  • 5.2 Global EGFR-TKI Consumption Value by Type (2021-2032)
  • 5.3 Global EGFR-TKI Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global EGFR-TKI Sales Quantity by Application (2021-2032)
  • 6.2 Global EGFR-TKI Consumption Value by Application (2021-2032)
  • 6.3 Global EGFR-TKI Average Price by Application (2021-2032)

7 North America

  • 7.1 North America EGFR-TKI Sales Quantity by Type (2021-2032)
  • 7.2 North America EGFR-TKI Sales Quantity by Application (2021-2032)
  • 7.3 North America EGFR-TKI Market Size by Country
    • 7.3.1 North America EGFR-TKI Sales Quantity by Country (2021-2032)
    • 7.3.2 North America EGFR-TKI Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe EGFR-TKI Sales Quantity by Type (2021-2032)
  • 8.2 Europe EGFR-TKI Sales Quantity by Application (2021-2032)
  • 8.3 Europe EGFR-TKI Market Size by Country
    • 8.3.1 Europe EGFR-TKI Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe EGFR-TKI Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific EGFR-TKI Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific EGFR-TKI Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific EGFR-TKI Market Size by Region
    • 9.3.1 Asia-Pacific EGFR-TKI Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific EGFR-TKI Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America EGFR-TKI Sales Quantity by Type (2021-2032)
  • 10.2 South America EGFR-TKI Sales Quantity by Application (2021-2032)
  • 10.3 South America EGFR-TKI Market Size by Country
    • 10.3.1 South America EGFR-TKI Sales Quantity by Country (2021-2032)
    • 10.3.2 South America EGFR-TKI Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa EGFR-TKI Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa EGFR-TKI Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa EGFR-TKI Market Size by Country
    • 11.3.1 Middle East & Africa EGFR-TKI Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa EGFR-TKI Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 EGFR-TKI Market Drivers
  • 12.2 EGFR-TKI Market Restraints
  • 12.3 EGFR-TKI Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of EGFR-TKI and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of EGFR-TKI
  • 13.3 EGFR-TKI Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 EGFR-TKI Typical Distributors
  • 14.3 EGFR-TKI Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on EGFR-TKI. Industry analysis & Market Report on EGFR-TKI is a syndicated market report, published as Global EGFR-TKI Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of EGFR-TKI market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo